Company News: Allergan (AGN) quarterly results beat analysts’ expectations

Market news

10 February 2020

Company News: Allergan (AGN) quarterly results beat analysts’ expectations

Allergan (AGN) reported Q4 FY 2019 earnings of $5.22 per share (versus $4.29 per share in Q4 FY 2018), beating analysts' consensus estimate of $4.53 per share.

The company's quarterly revenues amounted to $4.351 bln (+6.6% y/y), beating analysts' consensus estimate of $4.091 bln.

AGN rose to $197.66 (+0.31%) in pre-market trading.

Canada: Housing Starts, January 213 (forecast 202.5)

European session review: EUR little changed amid lingering fears about the coronavirus

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.